Expert consensus on prescription comment of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing.
10.19540/j.cnki.cjcmm.2018.0036
- Author:
Rui JIN
1
;
Kui-Jun ZHAO
2
;
Gui-Ming GUO
3
;
Bing ZHANG
4
;
Yu-Guang WANG
5
;
Chun-Miao XUE
6
;
Yi-Heng YANG
7
;
Li-Xia WANG
8
;
Guo-Hui LI
9
;
Jin-Fa TANG
10
;
Li-Xing NIE
11
;
Xiang-Lin ZHANG
12
;
Ting-Ting ZHAO
13
;
Yi ZHANG
14
;
Can YAN
15
;
Suo-Zhong YUAN
1
;
Lu-Lu SUN
1
;
Xing-Zhong FENG
1
;
Dan YAN
1
;
Null
Author Information
1. Beijing Key Laboratory of Bio-characteristic Profiling for Evaluation of Rational Drug Use, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
2. Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
3. Beijing Traditional Chinese Medical Hospital, Capital Medical University, Beijing 100010, China.
4. Beijing University of Chinese Medicine, Beijing 100029, China.
5. Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China.
6. Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100700, China.
7. Peking University Third Hospital, Beijing 100191, China.
8. Guang'anmen Hospital China Academy of Chinese Medical Sciences, Beijing 100053, China.
9. Cancer Hospital Chinese Academy of Medical Sciences, Beijing 100021, China.
10. The First Affiliated Hospital of Henan Chinese Medicine College, Zhengzhou 450008, China.
11. National Institutes for Food and Drug Control, Beijing 100050, China.
12. China-Japan Friendship Hospital, Beijing 100029, China.
13. Center for Drug Evaluation, China Food and Drug Administration, Beijing 100045, China.
14. Chongqing Academy for Food and Drug Control, Chongqing 401121, China.
15. Guangzhou University of Chinese Medicine, Guangzhou 510405, China.
- Publication Type:Journal Article
- Keywords:
Chinese traditional patent medicine;
expert consensus;
prescription comment;
rational use of drugs
- From:
China Journal of Chinese Materia Medica
2018;43(5):1049-1053
- CountryChina
- Language:Chinese
-
Abstract:
With the growth of number of Chinese patent medicines and clinical use, the rational use of Chinese medicine is becoming more and more serious. Due to the complexity of Chinese medicine theory and the uncertainty of clinical application, the prescription review of Chinese patent medicine always relied on experience in their respective, leading to the uncontrolled of clinical rational use. According to the traditional Chinese medicine (TCM) theory and characteristics of the unique clinical therapeutics, based on the practice experience and expertise comments, our paper formed the expert consensus on the prescription review of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing. The objective, methods and key points of prescription review of Chinese patent medicine, were included in this expert consensus, in order to regulate the behavior of prescription and promote rational drug use.
